Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

4 treatments under study, led by Eim Testing

Related Conditions

Often studied with 6 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Completed1
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Research Network

Common Treatments

  • Eim Testing1
  • Nerve Conduction Studies1
  • Nerve Amp Muscle Ultrasonography1
  • Electromyography Emg1

Active Sponsors

  • National Institute of Neurological Disorders and Stroke (NINDS)2

Top Investigators

Related Conditions

  • Inherited Neuropathies2
  • Neuromuscular Disease1
  • Hereditary Spastic Paraplegias1
  • Motor Neuron Disease1
  • Muscular Dystrophies1

Activity Timeline